Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response—final results from GeparSixto von Loibl, S., Weber, K.E., Timms, K.M., Elkin, E.P., Hahnen, E., Fasching, P.A., Lederer, B., Denkert, C., Schneeweiss, A., Braun, S., Salat, C.T., Rezai, M., Blohmer, J.U., Zahm, D.M., Jackisch, C., Gerber, B., Klare, P., Kümmel, S., Schem, C., Paepke, S., Schmutzler, R., Rhiem, K., Penn, S., Reid, J., Nekljudova, V., Hartman, A.-R., von Minckwitz, G., Untch, M.

Volltext

Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study) von Fasching, P.A., Link, T., Hauke, J., Seither, F., Jackisch, C., Klare, P., Schmatloch, S., Hanusch, C., Huober, J., Stefek, A., Seiler, S., Schmitt, W.D., Uleer, C., Doering, G., Rhiem, K., Schneeweiss, A., Engels, K., Denkert, C., Schmutzler, R.K., Hahnen, E., Untch, M., Burchardi, N., Blohmer, J.-U., Loibl, S.

Volltext

BRCA1 and BRCA2 genetic testing—pitfalls and recommendations for managing variants of uncertain clinical significance von Eccles, D.M., Mitchell, G., Monteiro, A.N.A., Schmutzler, R., Couch, F.J., Spurdle, A.B., Gómez-García, E.B., Driessen, R., Lindor, N.M., Blok, M.J., Moller, P., de la Hoya, M., Pal, T., Domchek, S., Nathanson, K., Van Asperen, C., Diez, O., Rheim, K., Stoppa-Lyonnet, D., Parsons, M., Goldgar, D.

Volltext

Phenotype analysis of families with TP53 germline variants at the Center for Familial Breast and Ovarian Cancer, Cologne von Kast, K., Rhiem, K., Larsen, M., Wappenschmidt, B., Schmutzler, R.

Volltext

EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy von Schmidt, Marjanka K., Kelly, Jennifer E., Brédart, Anne, Cameron, David A., de Boniface, Jana, Easton, Douglas F., Offersen, Birgitte V., Poulakaki, Fiorita, Rubio, Isabel T., Sardanelli, Francesco, Schmutzler, Rita, Spanic, Tanja, Weigelt, Britta, Rutgers, Emiel J.T.

Volltext

Implementation and evaluation of a nurse-led decision-coaching program for healthy breast cancer susceptibility gene (BRCA1/2) mutation carriers: a study protocol for the randomize... von Isselhard, A., Toepper, M., Berger-Hoeger, B., Steckelberg, A., Fischer, H., Vitinius, F., Beifus, K., Koeberlein-Neu, J., Wiedemann, R., Rhiem, K., Schmutzler, R., Stock, S.

Volltext

Germline mutation status and therapy response in patients with triple-negative breast cancer (TNBC): Results of the GeparOcto study von Pohl, E., Schneeweiss, A., Hauke, J., Moebus, V., Furlanetto, J., Denkert, C., Fasching, P.A., Hanusch, C., Tesch, H., Weber-Lassalle, N., Müller, V., Rhiem, K., Untch, M., Luebbe, K., Lederer, B., Jackisch, C., Nekljudova, V., Schmutzler, R.K., Hahnen, E., Loibl, S.

Volltext

Risk-adapted surveillance: focus on familial breast and ovarian cancer von Rhiem, K, Schmutzler, R K

Volltext

Auditory processing disorder in patients with language-learning impairment and correlation with malformation of cortical development von Boscariol, Mirela, Guimarães, Catarina Abraão, Hage, Simone R de Vasconcellos, Garcia, Vera Lucia, Schmutzler, Kátia M R, Cendes, Fernando, Guerreiro, Marilisa Mantovani

Volltext

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer von Tutt, Andrew N.J, Garber, Judy E, Kaufman, Bella, Viale, Giuseppe, Fumagalli, Debora, Rastogi, Priya, Gelber, Richard D, de Azambuja, Evandro, Fielding, Anitra, Balmaña, Judith, Domchek, Susan M, Gelmon, Karen A, Hollingsworth, Simon J, Korde, Larissa A, Linderholm, Barbro, Bandos, Hanna, Senkus, Elżbieta, Suga, Jennifer M, Shao, Zhimin, Pippas, Andrew W, Nowecki, Zbigniew, Huzarski, Tomasz, Ganz, Patricia A, Lucas, Peter C, Baker, Nigel, Loibl, Sibylle, McConnell, Robin, Piccart, Martine, Schmutzler, Rita, Steger, Guenther G, Costantino, Joseph P, Arahmani, Amal, Wolmark, Norman, McFadden, Eleanor, Karantza, Vassiliki, Lakhani, Sunil R, Yothers, Greg, Campbell, Christine, Geyer, Charles E

Volltext

BRCA1/2 testing: uptake, phenocopies, and strategies to improve detection rates in initially negative families von Fischer, C, Engel, C, Sutter, C, Zachariae, S, Schmutzler, R, Meindl, A, Heidemann, S, Grimm, T, Goecke, TO, Debatin, I, Horn, D, Wieacker, P, Gadzicki, D, Becker, K, Schäfer, D, Stock, F, Voigtländer, T

Volltext

Flächendeckende Versorgung von Familien mit erblichem Brust- und Eierstockkrebs von Rhiem, K, Schmutzler, R. K

Volltext

Platinum Sensitivity in a BRCA1 Mutation Carrier with Advanced Breast Cancer von Rhiem, K, Wappenschmidt, B, Bosse, K, Köppler, H, Tutt, A.N, Schmutzler, R.K

Volltext

Association of hormone receptor status with grading, age of onset, and tumor size in BRCA1-associated breast cancer von Graeser, M., Bosse, K., Brosig, M., Engel, C., Schmutzler, R. K.

Volltext

Overall survival in the OlympiA phase Ill trial of adjuvant olaparib in patients with germime pathogenic variants in BRCA1/2 and high-risk, early breast cancer von Geyer, C. E., Garber, J. E., Gelber, R. D., Yothers, G., Taboada, M., Ross, L., Rastogi, P., Cui, K., Arahmani, A., Aktan, G., Armstrong, A. C., Arnedos, M., Balmana, J., Bergh, J., Bliss, J., Delaloge, S., Domchek, S. M., Eisen, A., Elsafy, F., Fein, L. E., Fielding, A., Ford, J. M., Friedman, S., Gelmon, K. A., Gianni, L., Gnant, M., Hollingsworth, S. J., Im, S. A., Jager, A., Lakhani, S. R., Janni, W., Linderholm, Barbro, Liu, T. W., Loman, N., Korde, L., Loibl, S., Lucas, P. C., Marme, F., de Duenas, E. M., McConnell, R., Phillips, K. A., Piccart, M., Rossi, G., Schmutzler, R., Senkus, E., Shao, Z., Sharma, P., Singer, C. F., Spanic, T., Stickeler, E., Toi, M., Traina, T. A., Viale, G., Zoppoli, G., Park, Y. H., Yerushalmi, R., Yang, H., Pang, D., Jung, K. H., Mailliez, A., Fan, Z., Tennevet, I., Zhang, J., Nagy, T., Sonke, G. S., Sun, Q., Parton, M., Colleoni, M. A., Schmidt, M., Brufsky, A. M., Razaq, W., Kaufman, B., Cameron, D., Campbell, C., Tutt, A. N. J., Johannsson, O. T.

Volltext

Personalized early detection and prevention of breast cancer: ENVISION consensus statement von Pashayan, Nora, Antoniou, Antonis C., Ivanus, Urska, Esserman, Laura J., Easton, Douglas F., French, David, Sroczynski, Gaby, Hall, Per, Cuzick, Jack, Evans, D. Gareth, Simard, Jacques, Garcia-Closas, Montserrat, Schmutzler, Rita, Wegwarth, Odette, Pharoah, Paul, Moorthie, Sowmiya, De Montgolfier, Sandrine, Baron, Camille, Herceg, Zdenko, Turnbull, Clare, Balleyguier, Corinne, Rossi, Paolo Giorgi, Wesseling, Jelle, Ritchie, David, Tischkowitz, Marc, Broeders, Mireille, Reisel, Dan, Metspalu, Andres, Callender, Thomas, de Koning, Harry, Devilee, Peter, Delaloge, Suzette, Schmidt, Marjanka K., Widschwendter, Martin

Volltext

Rolandic discharges: Clinico-neurophysiological correlation von Medeiros, L.L, Yasuda, C, Schmutzler, K.M.R, Guerreiro, M.M

Volltext

Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer von Wirtenberger, Michael, Tchatchou, Sandrine, Hemminki, Kari, Schmutzhard, Julia, Sutter, Christian, Schmutzler, Rita K., Meindl, Alfons, Wappenschmidt, Barbara, Kiechle, Marion, Arnold, Norbert, Weber, Bernhard H. F., Niederacher, Dieter, Bartram, Claus R., Burwinkel, Barbara

Volltext

Limited relevance of the CHEK2 gene in hereditary breast cancer von Dufault, Michael R., Betz, Beate, Wappenschmidt, Barbara, Hofmann, Wera, Bandick, Katrin, Golla, Astrid, Pietschmann, Andrea, Nestle‐Krämling, Caroline, Rhiem, Kerstin, Hüttner, Christine, von Lindern, Celia, Dall, Peter, Kiechle, Marion, Untch, Michael, Jonat, Walter, Meindl, Alfons, Scherneck, Siegfried, Niederacher, Dieter, Schmutzler, Rita K., Arnold, Norbert

Volltext

Risk-reducing Surgery in Women at Risk for Familial Breast or Ovarian Cancer von Rhiem, K., Pfeifer, K., Schmutzler, R. K., Kiechle, M.

Volltext